Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of recombinant human platelet-derived growth factor gel for diabetic foot ulcer
CTR20220638Phase 2Active
- Sponsor
- Academy of Military Medical Sciences
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of becaplermin in diabetic foot ulcer (DFU), sponsored by Academy of Military Medical Sciences. Started Dec 2024; status: active.
02
Drugs
becaplermin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20220638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220638.